ISPE Updates

New Real-World Evidence Registry Launches

ISPE announces that the Real-World Evidence Transparency Initiative has launched the Real-World Evidence Registry. The Real-World Evidence Transparency Initiative is a partnership between ISPE, ISPOR, the Duke-Margolis Center for Health Policy, and the National Pharmaceutical Council. Read more here.

Do you want to shape the future and help lead ISPE?

Consider applying to serve on the Board of Directors for terms starting Aug 2022. The ISPE Nominating Committee is seeking candidates for election to the Society's Board of Directors for a 3-year term. 

Learn more here
Deadline: 11:00 pm EST Dec 31

Urgent Call for Comments: ISPE comments to RWD: Assessing Electronic Health Records and Medical Claims Data to Support Regulatory Decision-Making for Drug and Biologic Products

ISPE's Real-World Evidence Task Force's Regulatory Decision-making Subgroup has prepared comments for submission to the FDA. Per ISPE policy 1.7.2 Circumstances of Public Importance and/or Urgency, (see Policy Manual here), ISPE's Public Policy Committee chair has agreed the urgent review of these comments.
Learn more and access the comments paper here
Deadline: 11:00 pm EDT Oct 31

Call for ISPE Fellowship (FISPE) Applications

The ISPE Board of Directors established the membership category ISPE Fellow to recognize and advance leadership in the Society. This membership category is awarded upon recommendation by a committee of peers. Learn more and apply for an ISPE Fellowship here.
Deadline: 11:00 pm EST Dec 15

Congratulations to all our 2021 ICPE Award Winners

View ICPE awards video here

Call for Topics for ICPE 2022

Planning for ICPE 2022 is underway and we want your suggestions for plenary and hot topic speakers. View more information here
Deadline: 11:00 pm EDT Oct 31

Upcoming Webinars:

Interested in presenting a webinar? Submit a webinar proposal here